Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Talat Aykut
Observed name:
Talat AYKUT
Institution:
Necmettin Erbakan University
Observed institution:
Necmettin Erbakan University
ORCID:
0000-0002-9614-0651
Observed ORCID:
0000-0002-9614-0651
OpenAlex ID:
A5007003860
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2025
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Scientific Reports
·
9
PDF
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
2024
·
İsmail Beypınar
, Hacer Demir
, et al.
·
Breast Cancer Research and Treatment
·
5
Small cell lung cancer differentiation in patients with driver mutant non-small cell lung cancer: a single center experience
2025
·
Oğuzhan Yıldız
, Melek Karakurt Eryılmaz
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
3
PDF
Prognostic Significance of Albumin–Bilirubin (ALBI) Score in Gastric Cancer Patients Undergoing Curative Resection Followed by Adjuvant Therapy
2026
·
Talat Aykut
, Oğuzhan Yıldız
, et al.
·
Medicina
·
2
PDF
Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib
2025
·
Oğuzhan Yıldız
, Talat Aykut
, et al.
·
Medicina
·
2
PDF
Drug induced lupus associated with Trastuzumab emtansine in a patient with metastatic breast cancer
2024
·
Oğuzhan Yıldız
, Ali Fuat Gürbüz
, et al.
·
Journal of Oncology Pharmacy Practice
·
2
Prognostic Value of C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma
2026
·
Ali Fuat Gürbüz
, Mehmet Zahid Koçak
, et al.
·
Medicina
·
1
Comparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG)
2025
·
Ali Kalem
, Tulay Kus
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Sclerostin and TNF-related weak inducer of apoptosis: can they be important in the patients with glomerulonephritis?
2023
·
Hakan Ozer
, İsmail Baloglu
, et al.
·
Revista da Associação Médica Brasileira
·
1
PDF
The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease
2023
·
Kultigin Turkmen
, Ismail Baloglu
, et al.
·
Saudi Journal of Kidney Diseases and Transplantation
·
1
Regorafenib-Associated Pancreatic Atrophy and Survival Outcomes in Metastatic Colorectal Cancer
2026
·
Ali Fuat Gürbüz
, Melek Karakurt Eryılmaz
, et al.
·
Journal of Clinical Medicine
The Impact of Renin-Angiotensin System Inhibitors Combined with Panitumumab on Survival in RAS Wild-Type Metastatic Colorectal Cancer
2026
·
Talat Aykut
, Mehmet Zahid Koçak
, et al.
·
Bratislavské lekárske listy/Bratislava medical journal
Integrated Inflammatory and Nutritional Biomarkers in Metastatic Renal Cell Carcinoma Treated with Second- or Later-Line Nivolumab: A Retrospective Cohort Study
2026
·
Muzaffer Uğraklı
, Ülkü Kerimoğlu
, et al.
·
Medicina
Prognostic Role of Uric Acid-to-Albumin Ratio in Patients with Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
2026
·
Talat Aykut
, Mehmet Zahid Koçak
, et al.
·
Journal of Clinical Medicine
Correction: Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer
2026
·
Yasin Sezgin
, Oğur Karhan
, et al.
·
Scientific Reports
PDF
Prognostic Role of Modified Glasgow Prognostic Score in metastatic Renal Cell Carcinoma Patients Treated with Nivolumab: Single-Center Experience
2026
·
Oğuzhan Yildiz
, Melek Karakurt Eryılmaz
, et al.
·
Genel Tıp Dergisi
Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and Abiraterone
2026
·
Bahattin Engin Kaya
, Mehmet Zahid Koçak
, et al.
·
Medicina
PDF
Reduced efficacy of nivolumab following prior immunotherapy in metastatic renal cell carcinoma: Implications for sequential immune checkpoint inhibition
2026
·
Oğuzhan Yıldız
, Melek Karakurt Eryılmaz
, et al.
·
Experimental Biomedical Research
PDF
Survival Outcomes with Abiraterone versus Enzalutamide in Metastatic Prostate Cancer: A Real-World Single-Center Study
2026
·
Ali Fuat Gürbüz
, Oğuzhan Yıldız
, et al.
·
Van Medical Journal
PDF
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)
2025
·
Ali Kalem
, Tulay Kus
, et al.
·
Cancers
PDF
Leukocytoclastic vasculitis with purpura induced by panitumumab
2025
·
Oğuzhan Yıldız
, Murat Araz
, et al.
·
Oncology in Clinical Practice
PDF
FOLFIRINOX: The best adjuvant treatment for ampullary adenocarcinoma?
2025
·
Ali̇ Kalem
, Tulay Kus
, et al.
·
Journal of Clinical Oncology
Comparison of frontline FOLFIRINOX with fluorouracil-based and gemcitabine-basedchemotherapies in metastatic ampullary adenocarcinoma: A multicenter cohort study.
2025
·
Ali̇ Kalem
, Tulay Kus
, et al.
·
Journal of Clinical Oncology
PDF
What Do Donor-Specific Antibody Changes Mean in Kidney Transplant Patients?
2023
·
Talat AYKUT
, Hakan OZER
, et al.
·
Turkish Journal of Internal Medicine
PDF
Development of second primary multiple myeloma five years after treatment for limited-stage small cell lung cancer: a rare case report
2021
·
Melek Karakurt Eryılmaz
, Talat Aykut
, et al.
·
Oncology in Clinical Practice
PDF
Show more works
View as search
Works count:
26
Citation count:
27
H-index:
3
I10-index:
Year
Topic
Type